Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
about
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic miceOncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line AkataEpstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriersMicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathwaysEpstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationSpecificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopesEpstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Serological diagnosis of Epstein-Barr virus infection: Problems and solutionsEpstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic miceImmediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseZinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1The LMP2A ITAM is essential for providing B cells with development and survival signals in vivoIntron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genesInhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.CTCF prevents the epigenetic drift of EBV latency promoter QpEpigenetic regulation of EBV persistence and oncogenesis.Biology and disease associations of Epstein-Barr virus.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveRedefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesThe Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Histone acetylation and reactivation of Epstein-Barr virus from latency.Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.EBNA-LP associates with cellular proteins including DNA-PK and HA95.The Epstein-Barr virus and its association with human cancers.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.T-cell memory: lessons from Epstein-Barr virus infection in manThe role of EBV in post-transplant malignancies: a review.Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.EBV latency types adopt alternative chromatin conformations.Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinomaEBV Chronic InfectionsMolecular virology of Epstein-Barr virus.The immunology of Epstein-Barr virus infectionEpstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response
P2860
Q24524255-255F471C-5149-4A7F-ADCB-E7486DDB2279Q24527320-211AB726-508A-4FEF-81BA-945E2051DF83Q24561854-50FA9AB9-6199-47D7-B78B-5831D57309CBQ24650451-104112F1-E97A-49DB-B3C2-5DF74F140142Q24671870-D37FA581-029A-41BD-8269-3C7A5EA449B0Q24792319-AFB3B7FD-AC5B-4C55-9588-7C3E41BE9759Q24798984-DDD80C71-3D1A-42B8-BA1E-7624404AE280Q26829346-E0E11780-A996-45D2-AFC9-C4F3B2BF070CQ27345929-9AB34B6A-29E9-4FFF-8250-CC1FA4FC4FC1Q30442835-C3A8F0BE-EF7C-4C3B-8D38-8B9E9E06D356Q33466782-3CCCE263-EF0A-42AC-8871-A3BBC52CE8FDQ33604616-0CD61DD0-74D1-4B6B-B52B-2B2439028D5EQ33640843-90B0E140-8F36-4732-BEAD-C72DF441291DQ33649532-08E87ED6-9ED1-4C94-B392-90E804838C8CQ33653017-E67D93B4-3EC9-4AB4-905E-0F814BDA7EF3Q33668727-787F5C50-72B4-4A89-85F9-54E47253D4AFQ33723664-927A7BEA-4872-48CC-A947-77D912768B12Q33772230-B3255C2E-9E7E-4FCC-9EBB-80E925988F9FQ33783746-149FEEDA-C025-4AB2-8CCD-52276FF5BE39Q33784685-0CD3A364-9A56-4363-B6DD-F342D15FDB4BQ33787243-8C579075-7565-45CB-ABE4-0CF719A46072Q33787396-4F41528D-33EC-40C7-BF71-8A3B9925B4F5Q33792860-B20DDA1E-11E8-4B0B-AFD2-54D9A60474E4Q33796114-A7EE0A7C-2F22-4F6E-A0D6-AC6BE38827E2Q33821583-E904DEC2-6AB4-49F1-9A9A-FD3A511F8736Q33834888-C36144CF-7394-4F1C-AA5E-88D72050AB6BQ33842129-18112E50-8881-492C-ACD7-8C88B5834A3CQ33850943-C242F9F7-66C7-411D-985A-6ED289A6DE7DQ33882153-C75C3FFC-CDD6-4F65-80D1-04AF301786F8Q33884691-50EB72B2-1644-4AD8-AB58-5FB7053E61C5Q33898010-444A2FE0-129F-426C-8F8A-28FBAF5B03A4Q33905235-382F3C44-B723-4AA3-AD60-50AB8273D054Q33925488-1143FDB2-FC6D-4B8A-A786-7BD0B175600BQ33957851-D0DCA71A-9E22-4B84-ADDB-F88BEEA29F4BQ33987454-CA4BCB7A-B64D-4717-A8F1-361B6DF8AB4BQ34089491-450E0C62-D867-459A-BFBA-BB249584E2A9Q34171625-0BE80333-2820-414D-B237-BAFC9157DFEEQ34225554-44B0503C-B553-4284-BF5D-02CB35C93F97Q34225567-41DCF6FC-3820-4612-8892-4EDF79243065Q34227303-67BA50C8-94E2-4D72-883E-F047CC614006
P2860
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Epstein-Barr virus latency in ...... tion and in the carrier state.
@ast
Epstein-Barr virus latency in ...... tion and in the carrier state.
@en
type
label
Epstein-Barr virus latency in ...... tion and in the carrier state.
@ast
Epstein-Barr virus latency in ...... tion and in the carrier state.
@en
prefLabel
Epstein-Barr virus latency in ...... tion and in the carrier state.
@ast
Epstein-Barr virus latency in ...... tion and in the carrier state.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus latency in ...... ction and in the carrier state
@en
P2093
P2860
P304
P407
P577
1994-11-01T00:00:00Z